share_log

UBS Downgrades Omeros to Neutral, Lowers Price Target to $2

Benzinga Real-time News ·  Dec 8, 2022 08:32

UBS analyst Colin Bristow downgrades Omeros (NASDAQ:OMER) from Buy to Neutral and lowers the price target from $12 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment